In This Article:
The Swedish stock market has recently shown resilience, with the pan-European STOXX Europe 600 Index ending the week 1.85% higher, buoyed by an interest rate cut from the European Central Bank. Amidst this favorable environment, investors are on the lookout for undervalued stocks that offer potential for growth and stability. In this context, identifying value stocks such as Biotage involves looking at companies with strong fundamentals that may be temporarily overlooked by the market.
Top 10 Undervalued Stocks Based On Cash Flows In Sweden
Name | Current Price | Fair Value (Est) | Discount (Est) |
Sleep Cycle (OM:SLEEP) | SEK40.80 | SEK79.93 | 49% |
CTT Systems (OM:CTT) | SEK268.00 | SEK493.95 | 45.7% |
Husqvarna (OM:HUSQ B) | SEK66.00 | SEK130.09 | 49.3% |
QleanAir (OM:QAIR) | SEK26.30 | SEK51.22 | 48.7% |
Biotage (OM:BIOT) | SEK181.00 | SEK361.12 | 49.9% |
Stille (OM:STIL) | SEK220.00 | SEK439.93 | 50% |
Lindab International (OM:LIAB) | SEK266.20 | SEK522.48 | 49.1% |
Tourn International (OM:TOURN) | SEK8.52 | SEK16.49 | 48.3% |
Mentice (OM:MNTC) | SEK27.00 | SEK50.99 | 47.1% |
MilDef Group (OM:MILDEF) | SEK86.60 | SEK161.29 | 46.3% |
Let's dive into some prime choices out of the screener.
Biotage
Overview: Biotage AB (publ) offers solutions and products for drug discovery and development, analytical testing, and water and environmental testing, with a market cap of SEK14.49 billion.
Operations: The company's revenue segments include Healthcare Software, generating SEK2.08 billion.
Estimated Discount To Fair Value: 49.9%
Biotage is trading at SEK181, significantly below its estimated fair value of SEK361.12, making it highly undervalued based on discounted cash flows. Earnings are forecast to grow 20.4% annually, outpacing the Swedish market's 15.2%. Recent earnings reports show substantial growth with Q2 sales at SEK504 million compared to SEK409 million last year. Despite a low future Return on Equity (13.6%), Biotage's strong cash flow potential makes it an attractive consideration for investors seeking undervalued stocks in Sweden.
-
Insights from our recent growth report point to a promising forecast for Biotage's business outlook.
-
Navigate through the intricacies of Biotage with our comprehensive financial health report here.
Fortnox
Overview: Fortnox AB (publ) offers financial and administrative software solutions for small and medium-sized businesses, accounting firms, and organizations, with a market cap of SEK38.49 billion.
Operations: Revenue segments (in millions of SEK): Businesses: 378, Marketplaces: 160, Core Products: 734, Accounting Firms: 352, Financial Services: 249 Fortnox AB generates revenue through its core products (SEK734M), services for accounting firms (SEK352M), offerings for businesses (SEK378M), financial services (SEK249M), and marketplaces (SEK160M).